Connect with us

Business

Why ISWH May Be a Prime Turnaround Opportunity in the Making

Published

on

For those in search of speculative turnaround potential in the small and micro-cap market space, you could do a whole lot worse than International Spirits & Wellness Holdings, Inc. (OTCMKTS:ISWH). The big picture here is a diversified branding play with commercial-stage operations already in place in the CBD, Wellness, Home Healthcare, and Spirits industries, and development stage operations in the Renewable Energy and Supply Chain & Logistics markets.

Based on recent financial performance, the company may have recently gotten past the point where its operational cash flows can start to fully support its future growth investments. For any micro-cap, this is the golden point in the investment cycle: when growth becomes non-dilutive. ISWH is either at or very near this point, posting EBITDA profitability and triple-digit topline growth in Q3 and Q4 of 2019.

ISWH recently completed a shareholder-friendly restructuring and reverse stock split to better align its price-per-share quote with common standards for investor perception.

Pro-tip: In our experience, when a company has this much going for it, and then does this type of restructuring and realignment, it’s typically in front of a lot of major positive news. The shift in structure and share price is to set the stage so that the company’s existing long-term shareholders can get the most bang for the buck on new strong announcements set to roll out over coming weeks and months.

In other words, the stage is set for some big happy news for ISWH. Take note.

In the words of the company’s President and Chairman, Alonzo Pierce: “A shareholder-friendly restructuring was necessary to strengthen our relationship with capital markets, pursue a near-term uplist to a higher exchange tier, and set in motion our operational strategy for 2020. We have a number of very compelling catalysts set to roll out, but we needed to provide a viable context – to lay a foundation for that success – as an initial step. We have achieved that with our restructuring and reverse split last week.”

That just about says it all.

The Foundation

The foundation for ISWH right now is its two main commercial-stage growth drivers: CBD-based products and the company’s rapidly growing home healthcare business.

The CBD products segment is positioned for rapidly accelerating growth this year following the signing of its defining partnership agreement with BioPulse Labs, a nationally-recognized brand development and manufacturing leader in the nano-infusion of CBD products. The BioPulse agreement provides for effectively a starter package in product development and marketing for the fresh launch of five new CBD-based wellness products. That will effectively push a restart button for the company’s P19 brand of CBD-based products.

The company also has an edge through this partnership due to the fact that it will be that rare CBD products brand able to boast that all of its products are formulated and produced in FDA compliant and registered facilities. This is becoming a huge issue in the current world of garage-band CBD producers. Consumers don’t know what they’re getting when they purchase CBD products. And they’re starting to figure that out.

The Home Healthcare segment is rapidly expanding as well. This division saw quadruple-digit percentage growth during the back half of 2019, and the company has implied that this trend is set to continue in Q1 2020.

Home healthcare spending is expected to reach more than $186 billion in 2027, according to a recent analysis from the Centers for Medicare & Medicaid Services (CMS) Office of the Actuary. This vastly surpasses any other category of health care service spending, even including hospital inpatient care, physician and professional services, nursing facilities, prescription drugs, retail sales of medical products and anything else you can think of.

ISWH has put in place a strong operational footprint in this rapidly expanding market, and we would look for continued strong performance throughout 2020.

Conclusion

With this foundation in place, a possible inflection toward non-dilutive growth in the quarters ahead, and now standing on the other side of the company’s recent shareholder-friendly restructuring, ISWH is an extremely interesting speculative opportunity, especially given our assumption that the company is getting ready to add some very strong new catalysts into the mix in coming weeks.

ISWH management drove this same sense home in its latest release: “This is truly all about embracing a very aggressive growth-oriented future path at ISWH,” continued Pierce. “We have put in place a winning framework as a genuine disruptor in the health and wellness space, and we continue to see dramatic growth in that endeavor, including strong financial performance over recent quarters. We are also entering several new markets, with a true edge already in place, and will be providing details on those strategic moves over the very near term. Long story short: we have some very exciting announcements ahead and we wanted to provide a solid structural foundation in the stock ahead of those catalysts for the benefit of our committed shareholders.”

Business

Charlotte’s Web Holdings Inc (OTCMKTS:CWBHF) Forms CW Labs To Strengthen Development Of Innovative High-Quality Hemp Derived Products And Delivery Systems

Published

on

Charlotte’s Web Holdings Inc (OTCMKTS:CWBHF) has formed a new division Charlotte’s Web Labs (CW Labs) to develop innovative high-quality products and delivery systems. It is an expansion of Charlotte’s efforts that focuses on hemp-derived terpenes, phytocannabinoids, and flavonoid compounds.

Tim Orr to head CW Labs

Tim Orr, who is recently hired by Charlotte as Senior Vice President, will head the CW Labs team of internal and external research specialists located in Boulder, Colorado, and Buffalo, New York.

Orr brings three decades of experience

Mr. Orr brings over three decades of experience in product development and commercial roles in life sciences, diagnostics, and medical device industries. His previous stints include management and top executive positions at Abbott Laboratories and Johnson & Johnson.

Mr. Orr said he is pleased to support the scientific discovery and innovation of Charlotte’s by leading CW Labs. The newly formed R&D lab will engage in the development of innovative delivery systems and high-quality products to the trusted and loyal customers of Charlotte. Science is driving the development of new formulations and improving their efficiencies.

Trusted hemp extracts

Charlotte is engaged in the production of trusted hemp extracts in the world. The company advances the science of full-spectrum extracts derived from hemp to express cannabinol (CBN), cannabigerol (CBG), cannabidiolic acid (CBDA), cannabichromine (CBC), cannabidiol (CBD), and other hemp-derived compounds.

CW Labs will help Charlotte in advancing the product line through science-based innovation and facilitates clinical trials. It is already engaged in placebo-controlled and double-blinded human clinical trials involving hemp-derived solutions for the needy in several states. Chief Executive Officer of Charlotte, Deanie Elsner said the formation of CW Labs improves the reach of Charlotte into the safety, efficiency and the science of hemp plant compounds. Deanie further said the launch of CW Labs shows its commitment to lead the innovation and introduce cutting edge solutions using hemp.

Charlotte has completed the audit of the hemp harvest for 2019. Deanie said the company is excited with 2019 harvest, potency and yield levels. It shows the tremendous expertise gained by the company in hemp cultivation over the past six years.

Continue Reading

Business

HempAmericana Inc (OTCMKTS:HMPQ) is a Turnaround Prospect

Published

on

Turnaround stories are widely sought and difficult to find, which is why we want to cast a focus on HempAmericana Inc (OTCMKTS:HMPQ) today, as the company positions itself as a long-term beneficiary of the CBD-based products boom – something that has gone undercover so far in 2020 even though it remains possibly one of the most reliably potent large timeframe success stories of the coming decade, according to many prominent analysts.

The big idea here is still unquestionably that of a “mainstreaming” process – the CBD products marketplace is defined by a “small to big” dynamic that is all about a niche product crowd growing into a very widely accepted household goods market. The CBD growth trend that many investors have heard about over the past several years is simply about discovery.

But, even as that process plays out in empirically visible ways, stocks in the space have been carved up due to over-competition.

That said, the sweeping bear market that has ravaged the space has driven many of the less well-founded names into oblivion. Naturally, that’s the point of a bear market: to burn up the excess fat, leaving a leaner, meaner industry to more efficiently monetize the total base of industrial and intellectual capital. It’s the essence of a market-based system.

In this case, HempAmericana Inc (OTCMKTS:HMPQ) is one of the survivors.

As is always the case in such circumstances, the survivors are very deeply undervalued at this point – they’ve been through the ravages of the bear. They’ve been stripped down to nothing. But, at the same time, they’ve also survived to tell the tale. That alone makes them worth a very serious measure of attention. The survivors of a focused bear market in a specific sector often historically represent some of the most powerful opportunities. They are the babies that almost, but not quite, got thrown out with the bathwater. And those are some underpriced babies.

HMPQ belongs to that thematic group right now. The stock is trading at bargain-basement levels in sub-penny territory. But it has real operations and a first-class extraction and production facility in Maine, with ramping resources and a path of very likely tangible top-line growth over the coming period of months. While shareholders of the company may have heard that sentiment before, there are reasons to see this moment as different – as more urgently promising.

 

Spring is in the Air

In HMPQ’s case, business is picking back up, and the company has reportedly stored up an inventory of top-tier products that is ready to be monetized. The company has also just launched its new ecommerce platform to help with that process, complete with an active payment processor capable of taking major credit and debit cards seamlessly, which is a major accomplishment.

“The new website has been designed to offer the ultimate user-friendly experience with an improved ease of use and functionality while allowing customers to see the wide variety of full-spectrum CBD oils the Company offers. We upgraded the website with our customers in mind, the site includes more information about our products such as our COAs, to help buyers find the right CBD product they need, and to instill better Confidence in this age of uncertainty,” stated Company CEO Sal Rosillo.

Note, according to its most recent release, the company wasn’t able to process orders due to a change in Policy with the PayPal Platform not allowing Hemp related product sales. The company has retained an Industry-leading payment processor that accepts payment for Hemp products. The company is very pleased to have been approved to accept credit cards through First Direct Financial.

That’s an enormous plus. The company’s web presence is live and active, and first-rate. And it has the capacity to do business with customers in convenient terms. In this case, that’s a biggie.

HempAmericana Inc (OTCMKTS:HMPQ) bills itself as an emerging player in the hemp-based CBD marketplace. The company also researches, develops and sells products made of industrial hemp, in addition to carrying out other non-hemp based products but intends to focus primarily on the potential for hemp.

In essence, anything that can be made with plastic can be made with industrial hemp and HempAmericana plans to fill the growing need and demand for hemp-based products within the United States. The company also intends to explore other possible business avenues relating to the legal use of the Cannabis plant.

But the big one right now is clearly about establishing scaling growth in its CBD-based products segment. There is every reason to believe we may be witnessing the roots of that right now, and in concert with the roots taking hold for an overall bottoming of the cannabis, hemp, and CBD market as a whole.

Continue Reading

Business

Acreage Holdings Inc (OTCMKTS:ACRGF) Inaugurates A Medical Dispensary – The Botanist In Spring Hill, Florida: Larissa Herda Resigns From The Board of Acreage

Published

on

Acreage Holdings Inc (OTCMKTS:ACRGF) inaugurated The Botanist in the Spring Hill, Florida. It is the first medical cannabis dispensary of Acreage in the state. The company now holds consulting and management services and other accords that include pending takeovers for thirty-two operational dispensaries in thirteen states that comprise fourteen The Botanist branded dispensaries. Acreage invests in cannabis industries.

The Botanist Brand

The Botanist Brand, which is developed by Acreage, is a product and retail brand with deep roots in wellness and health. It helps individuals to maintain healthy lifestyles using the holistic power of cannabis. The Botanist provides a wide gamut of products derived from cannabis. It also features a retail design – the science meets nature, which is reminiscent of the nineteenth-century botanist laboratory. The Botanist in the Spring Hill boasts its signature green foliage wall and a private consultation room and provides an environment for enthusiasts like you to know about the healing properties of cannabis plants from the trained specialists in patient-care.

Larissa Herda resigns from the board

According to a communiqué from Acreage, Larissa Herda has relinquished as a member of the board. Kevin Murphy, Chief Executive Officer and Chair of Acreage said the company conveyed thanks for her exceptional services all along its journey since joining the board in November 2018 and wished success in her future endeavors.

Closes previously announced credit facility

Acreage has successfully closed the previously announced credit facility of $100 million. It has drawn $21 million from this credit facility. The subsidiary of Acreage – IP Borrower has also borrowed $22 million from IP Investment Company LLC.

Acreage has agreed to make monthly payments at an annual interest of 3.55% on the first advance, 1.85% on the second advance, and 1.55% for the third advance for the first year. It will negotiate interest rates for the second year. IP Borrower provides a guarantee for the credit facility. It will also provide security of $22 million from the loan transaction. The amount of $22 million will be blocked in the account as a safety to the Institutional lender.

The Borrower needs to provide cash collateral to draw the balance amount of $78 million. However, the institutional lender will not hold any security in the subsidiaries of Acreage or Acreage.

Continue Reading

FEATURED STORIES

Business13 hours ago

Charlotte’s Web Holdings Inc (OTCMKTS:CWBHF) Forms CW Labs To Strengthen Development Of Innovative High-Quality Hemp Derived Products And Delivery Systems

Post Views: 218 Charlotte’s Web Holdings Inc (OTCMKTS:CWBHF) has formed a new division Charlotte’s Web Labs (CW Labs) to develop...

Business15 hours ago

HempAmericana Inc (OTCMKTS:HMPQ) is a Turnaround Prospect

Post Views: 602 Turnaround stories are widely sought and difficult to find, which is why we want to cast a...

Business4 days ago

Acreage Holdings Inc (OTCMKTS:ACRGF) Inaugurates A Medical Dispensary – The Botanist In Spring Hill, Florida: Larissa Herda Resigns From The Board of Acreage

Post Views: 425 Acreage Holdings Inc (OTCMKTS:ACRGF) inaugurated The Botanist in the Spring Hill, Florida. It is the first medical...

Business5 days ago

TerrAscend Canada Inc, A Subsidiary Of Terrascend Corp (OTCMKTS:TRSSF), Enters A $80.5 Million CAD Loan Financing Accord With Canopy Growth Corp (NYSE:CGC)

Post Views: 460 TerrAscend Canada Inc, a subsidiary of Canopy Rivers Inc (OTCMKTS:CNPOF), has entered into an $80.5 Million CAD...

Business6 days ago

Medipharm Labs Corp (OTCMKTS:MEDIF) Expects To Begin Supply Of Pharmaceutical-quality cannabis oil products in Australia

Post Views: 523 Medipharm Labs Corp (OTCMKTS:MEDIF) will supply pharmaceutical quality cannabis oil products in Australia. It is on the...

Business6 days ago

Kannalife Inc (OTCMKTS:KLFE) Announces Receipt Of Australian Patent To Treat Hepatic Encephalopathy

Post Views: 381 Kannalife Inc (OTCMKTS:KLFE), a portfolio company of Medical Marijuana Inc (OTCMKTS:MJNA), has received an Australian patent No....

Whats Hot